Latest News

UAE reaches 15,000 vaccinated volunteers target for Phase III of COVID-19 vaccine trial

WAM

The world’s first Phase III trials of an inactivated vaccine for COVID-19 in the United Arab Emirates have reached the 15,000 volunteers target in less than a month with individuals from 107 nationalities participating in the programme.

Managed by G42 Healthcare in partnership with the UAE Ministry of Health and Prevention (MOHAP), the Department of Health – Abu Dhabi, and Abu Dhabi Health Services Company (SEHA), the trials successfully screened and vaccinated 15,000 volunteers with the first of two vaccine shots they are given during the process. The inactivated vaccine has been developed by Sinopharm CNBG, a leading vaccine manufacturer.

Volunteers can still register through the portal www.4humanity.ae.

Moving forward, volunteers are entering the next stage, receiving their second shot, and continuing to undergo regular monitoring and health checks, with full ongoing support provided by the health services to ensure their wellbeing.

Since launching on 16th July in Abu Dhabi, the #4Humanity trials captured the imagination of the UAE’s multinational population eager to help fulfill the UAE leadership’s commitment to overcoming the pandemic through a global collaborative effort.

The volunteers encompass 107 nationalities and diverse demographics, including more than 4,500 Emiratis. Over 140 doctors, 300 nurses, and much more administrative and technical support staff are helping to facilitate the vaccine trial.

Volunteers have benefited from quick and simple protocols, enabling them to easily access walk-in centres at ADNEC in Abu Dhabi and Al Qarain Health Center in Sharjah to be registered, screened and administered their first vaccination in one visit.

The UAE Ministry of Health and Prevention (MOHAP), the Department of Health – Abu Dhabi, Abu Dhabi Health Services Company, Sinopharm and G42 Healthcare extended their gratitude to all volunteers for their service for humanity. Thanks to their participation in these historic trials, the world has taken a major step towards developing the first tested, safe vaccine.

Commenting on the achievement of this milestone, Abdul Rahman bin Mohammed Al Owais, Minister of Health and Prevention, said, “This is a very proud day for everyone associated with these trials and we are looking forward to continuing to play an integral role in the work to come in the months ahead.”

Sheikh Abdullah bin Mohammed Al Hamed, the Chairman of the Department of Health – Abu Dhabi, was the first individual in the world to commence the trial of Phase III inactivated vaccine for COVID-19 and has already received the first and second shot.

He added, “I was enormously proud to have been the first volunteer and since then it has been truly heartwarming to see how the nation has pulled together, helping us achieve our target of participants in just four weeks since the trials began. We are a nation of extraordinary people, one that individuals from all over the world call home, and together we are committed to finding a global solution for COVID-19.”

The trial is part of a series of national initiatives to foster population health and to enhance the UAE’s medical research and development capabilities, including the local capacity to manufacture the vaccine.

Staff Report

The Filipino Times is the chronicler of stories for, of and by Filipinos all over the world, reaching more than 236 countries in readership. Any interesting story to share? Email us at [email protected]

Related Articles

Back to top button